Yahoo Finance Top Growth Stocks To Buy
Looking to enhance your portfolio with high-growth, financially-robust stocks, but not sure where you should even begin? Stocks such as Malibu Boats and Shake Shack are deemed to be superior in terms of how much they’re expected to earn and return to shareholders, according to analysts. If your holdings could benefit from diversification towards growth stocks, whether it be in reputable tech stocks or green small-caps, take a look at my list of stocks with a bright future ahead.
Malibu Boats, Inc. (NASDAQ:MBUU)
Malibu Boats, Inc. designs, manufactures, distributes, markets, and sells recreational powerboats. Started in 1982, and now run by Jack Springer, the company provides employment to 586 people and with the company’s market capitalisation at USD $923.68M, we can put it in the small-cap group.
Driven by the positive double-digit sales growth of 26.17% over the next few years, MBUU is expected to deliver an excellent earnings growth of 42.35%. An affirming signal is when net income increase is supported by top-line growth. Since net income isn’t artificially inflated by one-off initiatives such as cost-cutting, we know this profit growth is more likely to be sustainable. We see this bottom-line expansion directly benefiting shareholders, with expected return on equity coming in at a notable 24.81%. MBUU ticks the boxes for robust growth generation on all levels of line items, which makes it an appealing stock to dig into deeper. Considering MBUU as a potential investment? Take a look at its other fundamentals here.
Shake Shack Inc. (NYSE:SHAK)
Shake Shack Inc. owns, operates, and licenses Shake Shack restaurants (Shacks) in the United States and internationally. Established in 2004, and currently headed by CEO Randall Garutti, the company employs 4,440 people and with the market cap of USD $2.15B, it falls under the mid-cap category.
SHAK is expected to deliver a buoyant earnings growth over the next couple of years of 41.31%, bolstered by an equally impressive revenue growth of 61.50%. An affirming signal is when net income increase is supported by top-line growth. Since net income isn’t artificially inflated by one-off initiatives such as cost-cutting, we know this profit growth is more likely to be sustainable. This prospective profitability should trickle down to shareholders, with analysts expecting the company to generate a positive return on equity of 12.49%. SHAK’s bullish prospects on both the top and bottom lines make it an interesting stock to invest more time to understand how it can add value to your portfolio. Want to know more about SHAK? Take a look at its other fundamentals here.
Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM)
Bellicum Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers, solid tumors, and orphan inherited blood disorders in the United States and internationally. Established in 2004, and currently headed by CEO Richard Fair, the company size now stands at 137 people and has a market cap of USD $342.98M, putting it in the small-cap group.
BLCM is expected to deliver a buoyant earnings growth over the next couple of years of 28.90%, bolstered by a significant revenue which is expected to more than double. Profit growth, coupled with top-line expansion, is a positive indication. This is because net income isn’t artificially inflated by unsustainable activities such as one-off cost-reductions expected in the future. BLCM’s bullish prospects on both the top and bottom lines make it an interesting stock to invest more time to understand how it can add value to your portfolio. Considering BLCM as a potential investment? Check out its fundamental factors here.
For more financially robust companies with high growth potential to enhance your portfolio, explore this interactive list of fast growing companies.
To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.
The author is an independent contributor and at the time of publication had no position in the stocks mentioned.
